azomycin has been researched along with carbostyril in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (5.26) | 18.7374 |
| 1990's | 2 (10.53) | 18.2507 |
| 2000's | 4 (21.05) | 29.6817 |
| 2010's | 9 (47.37) | 24.3611 |
| 2020's | 3 (15.79) | 2.80 |
| Authors | Studies |
|---|---|
| Burette, A; Glupczynski, Y | 1 |
| Munro, R; Shanker, S; Toohey, M | 1 |
| Walker, CB | 1 |
| Yeager, H | 1 |
| Brun, R; Ma, X; Zhou, W | 1 |
| Chevreuil, M; Eurin, J; Le Bot, B; Mercier, F; Tamtam, F | 1 |
| Lu, C; Wu, Z; Xiao, N; Yang, M; Zhao, X | 1 |
| Chen, X; Hou, J; Liu, H; Qian, Y; Wang, F; Xi, J; Xie, W | 1 |
| Bahia, MT; Buckner, FS; Charman, SA; Chatelain, E; Chennamaneni, NK; Gelb, MH; Hulverson, MA; Laydbak, JU; Lepesheva, GI; Scandale, I; Shackleford, DM; Suryadevara, PK; Verlinde, CL; White, KL | 1 |
| Cambau, E; Guillard, T | 1 |
| Bazzoli, F; Calvet, X; Fallone, C; Fischbach, L; Ford, AC; Forman, D; Gisbert, JP; Khan, KJ; Leontiadis, GI; Moayyedi, P; Oderda, G; Tse, F; Yuan, Y | 1 |
| Cheng, H; Li, Q; Wang, H; Wang, J; Wang, S; Xing, J; Zhang, H; Zhou, J | 1 |
| Keum, YS; Park, SW; Patel, RV | 1 |
| Nath, M; Tandon, R | 1 |
| Duarte, RV; Franik, S; Fuhrich, DG; Ross, J; Savaris, RF | 1 |
| Chen, D; Fang, C; Gao, J; Guo, Q; Wang, Y; Zhao, Y; Zhou, S | 1 |
| Kumar, S; Kumar, V; Legac, J; Raj, R; Rosenthal, PJ; Saini, A | 1 |
| Duarte, RV; Fuhrich, DG; Maissiat, J; Ross, J; Savaris, RF | 1 |
| Hussar, DA | 1 |
10 review(s) available for azomycin and carbostyril
| Article | Year |
|---|---|
Drug therapy for Helicobacter pylori infection: problems and pitfalls.
Topics: Anti-Bacterial Agents; Drug Resistance, Microbial; Helicobacter Infections; Helicobacter pylori; Humans; Macrolides; Nitroimidazoles; Quinolones | 1990 |
Selected antimicrobial agents: mechanisms of action, side effects and drug interactions.
Topics: Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; Cell Membrane Permeability; Cell Wall Skeleton; Cephalosporins; Clindamycin; Drug Interactions; Humans; Macrolides; Nitroimidazoles; Nucleic Acid Synthesis Inhibitors; Penicillins; Quinolones; Rifamycins; Tetracyclines | 1996 |
New drugs and vaccines.
Topics: Anti-Bacterial Agents; Drug Therapy, Combination; Fluoroquinolones; Humans; Mycobacterium bovis; Mycobacterium tuberculosis; Nitroimidazoles; Quinolones; Rifamycins; Tuberculosis; Tuberculosis Vaccines; World Health Organization | 2007 |
Meta-analysis of antibiotic prophylaxis use in transrectal prostatic biopsy.
Topics: Antibiotic Prophylaxis; Biopsy; Humans; Male; Nitroimidazoles; Prostate; Quinolones; Randomized Controlled Trials as Topic; Transurethral Resection of Prostate | 2009 |
Antimicrobials that affect the synthesis and conformation of nucleic acids.
Topics: Anti-Infective Agents; Coumarins; DNA Replication; DNA, Bacterial; Nitrofurans; Nitroimidazoles; Nucleic Acid Conformation; Nucleic Acids; Pyrimidines; Quinolones; Rifamycins; Sulfanilamides; Transcription, Genetic | 2012 |
Optimum duration of regimens for Helicobacter pylori eradication.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Nitroimidazoles; Proton Pump Inhibitors; Quinolones | 2013 |
Nitroimidazoles, Quinolones and Oxazolidinones as Fluorine Bearing Antitubercular Clinical Candidates.
Topics: Animals; Antitubercular Agents; Drug Discovery; Fluorine; Humans; Nitroimidazoles; Oxazolidinones; Quinolones; Tuberculosis | 2015 |
Tackling Drug-Resistant Tuberculosis: Current Trends and Approaches.
Topics: Antitubercular Agents; Benzothiazoles; Cell Wall; Clinical Trials as Topic; Ethylenediamines; Mycobacterium tuberculosis; Nitroimidazoles; Quinolones; Rifamycins; Tuberculosis, Multidrug-Resistant | 2017 |
Antibiotic therapy for pelvic inflammatory disease.
Topics: Adolescent; Adult; Aminoglycosides; Anti-Bacterial Agents; Azithromycin; Cephalosporins; Clindamycin; Doxycycline; Female; Humans; Nitroimidazoles; Pelvic Inflammatory Disease; Publication Bias; Quinolones; Randomized Controlled Trials as Topic | 2017 |
Antibiotic therapy for pelvic inflammatory disease.
Topics: Adolescent; Adult; Aminoglycosides; Anti-Bacterial Agents; Azithromycin; Cephalosporins; Clindamycin; Doxycycline; Drug Therapy, Combination; Female; Humans; Nitroimidazoles; Pelvic Inflammatory Disease; Publication Bias; Quinolones; Randomized Controlled Trials as Topic | 2020 |
9 other study(ies) available for azomycin and carbostyril
| Article | Year |
|---|---|
In vitro activity of seventeen antimicrobial agents against Gardnerella vaginalis.
Topics: 4-Quinolones; Anti-Bacterial Agents; Anti-Infective Agents; Cefoperazone; Cephalosporins; Clindamycin; Drug Resistance, Microbial; Erythromycin; Gardnerella vaginalis; Haemophilus; Imipenem; Microbial Sensitivity Tests; Nitroimidazoles; Quinolines; Quinolones; Thienamycins | 1982 |
Synthesis, in vitro antitrypanosomal and antibacterial activity of phenoxy, phenylthio or benzyloxy substituted quinolones.
Topics: Animals; Anti-Bacterial Agents; Antineoplastic Agents; Chagas Disease; Chemistry, Pharmaceutical; Drug Design; Drug Evaluation, Preclinical; Humans; Inhibitory Concentration 50; Magnetic Resonance Spectroscopy; Models, Chemical; Nitroimidazoles; Quinolones; Trypanocidal Agents; Trypanosoma cruzi | 2009 |
Ultra performance liquid chromatography tandem mass spectrometry performance evaluation for analysis of antibiotics in natural waters.
Topics: Anti-Bacterial Agents; Chromatography, Liquid; Fluoroquinolones; Mineral Waters; Molecular Structure; Nitroimidazoles; Pyrimidines; Quinolones; Reproducibility of Results; Solid Phase Extraction; Stereoisomerism; Sulfonamides; Tandem Mass Spectrometry | 2009 |
[Simultaneous determination of multi-veterinary drug residues in honey by solid phase extraction-high performance liquid chromatography-tandem mass spectrometry].
Topics: Animals; Chromatography, High Pressure Liquid; Drug Residues; Food Contamination; Honey; Nitroimidazoles; Quinolones; Solid Phase Extraction; Sulfonamides; Tandem Mass Spectrometry | 2011 |
Pharmacological characterization, structural studies, and in vivo activities of anti-Chagas disease lead compounds derived from tipifarnib.
Topics: 14-alpha Demethylase Inhibitors; Administration, Oral; Alkyl and Aryl Transferases; Animals; Chagas Disease; Crystallography, X-Ray; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Administration Schedule; Female; Humans; Mice; Models, Molecular; Nitroimidazoles; Quinolones; Structure-Activity Relationship; Triazoles; Trypanocidal Agents; Trypanosoma cruzi | 2012 |
Design, synthesis, antibacterial evaluation and docking study of novel 2-hydroxy-3-(nitroimidazolyl)-propyl-derived quinolone.
Topics: Anti-Bacterial Agents; Drug Design; Microbial Sensitivity Tests; Models, Biological; Molecular Docking Simulation; Molecular Structure; Nitroimidazoles; Quinolones; Staphylococcus aureus | 2015 |
[Determination of 125 veterinary drugs residues in eggs by QuEChERS-ultra-high performance liquid chromatography-tandem mass spectrometry].
Topics: Animals; Anti-Bacterial Agents; Benzimidazoles; Chloramphenicol; Chromatography, High Pressure Liquid; Drug Residues; Eggs; Glucocorticoids; Hormones; Macrolides; Nitroimidazoles; Quinolones; Solid Phase Extraction; Sulfonamides; Tandem Mass Spectrometry; Tetracyclines; Veterinary Drugs | 2018 |
Amalgamating Isatin/Indole/Nitroimidazole with 7-chloroquinolines via azide-alkyne cycloaddition: Synthesis, anti-plasmodial, and cytotoxic evaluation.
Topics: Alkynes; Antimalarials; Azides; Cycloaddition Reaction; Drug Screening Assays, Antitumor; Humans; Indoles; Isatin; Nitroimidazoles; Quinolones; Structure-Activity Relationship | 2020 |
New drugs 2020, part 3.
Topics: Aminophenols; Antibodies, Monoclonal, Humanized; Azabicyclo Compounds; Benzodioxoles; beta-Cyclodextrins; Cilastatin; Drug Approval; Drug Combinations; Ethinyl Estradiol; Genetic Vectors; Humans; Imipenem; Indoles; Nitroimidazoles; Pregnanolone; Pregnenediones; Pyrazoles; Pyridines; Pyrrolidines; Quinolones; Retinoids; United States; United States Food and Drug Administration | 2020 |